Catalyst Pharmaceuticals

Catalyst Pharmaceuticals

Pharmaceuticals
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

$2.9B

Market Cap • 1/20/2026

2006

(20 years)

Founded

2006

(20 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country